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ABSTRACT 14 
Purpose.  A woman’s skull, exhibiting features of lepromatous leprosy (LL), was recovered 15 
from a garden in Hoxne, Suffolk. The absence of post crania and lack of formal excavation 16 
meant that diagnosis and dating was uncertain. The aim of this research was to confirm the 17 
diagnosis using biomolecular means and second, to place it in context with other British 18 
leprosy cases using SNP genotyping and radiocarbon dating.  19 
Methodology.  Bone from the skull was analysed by ancient DNA (aDNA) methods and 20 
subjected to radiocarbon dating. As a result, stable carbon and nitrogen isotope values were 21 
produced, both useful for assessing aspects of the woman’s diet.  22 
Key findings. aDNA confirmed the presence of mycobacterium leprae and genotyping 23 
demonstrated an ancestral variant of subtype 3I, the same lineage recently identified in living 24 
squirrels in the south of England.  Radiocarbon dating revealed the woman lived 25 
approximately between 885-1015AD, providing evidence for endurance of this subtype in 26 
East Anglia, having been previously identified as early as the 5th-6th century (Great 27 
Chesterford) and as late as the 13th century (Ipswich).  28 
Conclusions. The confirmation of a new pre-Norman leprosy case in East Anglia is of 29 
interest as this is where a high proportion of cases are located. Possible factors for this may 30 
include preservation and excavation biases, population density, but also connection and 31 
trade, possibly of fur, with the continent. Future research on other British LL cases should 32 
focus on exploring these aspects to advance understanding of the disease’s history, here 33 
and on the continent.  34 
 35 
INTRODUCTION and AIMS. 36 
At some point between 1960 and 1990, a cranium and mandible with pathological changes 37 
consistent with leprosy were recovered from a garden in Hoxne, Suffolk (Anderson 1996). 38 
Unfortunately, little is known about the skull although a pre-Norman date (5th-11th century) 39 
was suggested based on the morphology of the skull [1]. With the exception of a second 40 
mandible, it is not known whether the cranium and mandible were associated with any other 41 
skeletal material. The bones are currently stored at Diss museum under accession numbers 42 
DISDS T.439.1-2. The cranium and mandible were first analysed osteologically by Sue 43 
Anderson of Suffolk County Council Archaeological Service in 1996 (see supplementary 44 
information or [1] for full report). Apart from the right side (ascending ramus) of the mandible, 45 
the skull was complete. The preservation of the material was very good. Anderson reported 46 
the skull to belong to a young to middle aged adult female [1]. Changes associated with 47 
Hansen’s disease included rhino-maxillary changes, especially destruction to the nasal 48 
spine, remodelling of nasal aperture margins (see Fig. 1) and palate [2]. Although these 49 
bone changes are highly indicative of leprosy, they are not unique to the condition and can 50 
be associated with other diseases. Without the rest of the skeleton to assess for other 51 
characteristic skeletal lesions (e.g. foot and hand deformities), a definite diagnosis of leprosy 52 
could not be made from the osteological changes alone. Given the potential early date of the 53 
woman, it would therefore be of interest to confirm the diagnosis of leprosy, and if possible, 54 
assess the strain to understand more about the temporal and geographic distribution of 55 
leprosy in ancient Britain. Although many strains of leprosy exist, recent research has 56 
demonstrated that at least two distinct strains of leprosy existed in Medieval England. Type 3 57 
strains were present from the 5th-6th century [3], while strains from the second branch (type 58 
2F strains) are known from the 11th century [4]. 59 
Therefore, the first aim of the current research was to assess the woman’s bone for the 60 
presence of Mycobacterium leprae, the bacteria that causes the disease, using genetic 61 
techniques. If mycobacteria were detected and the osteological leprosy diagnosis confirmed, 62 
the second aim was to assess which strain of leprosy infected the woman and how this fits 63 
into current knowledge about the disease. This required radiocarbon dating and comparison 64 
to other cases of leprosy in Britain. Overall, this research on a putatively pre-Norman case, 65 
contributes knowledge useful for understanding the nature of the leprosy epidemic that 66 
afflicted Britain and Europe in the medieval period.  67 
 68 
Fig.1. 69 
 70 
METHODS.  71 
 72 
DNA sampling. 73 
Sampling of the skull was undertaken in the museum store in Diss, Norfolk using gloves, a 74 
sterile scalpel and sampling bags.  Samples of bone powder (80 mg) were taken from the 75 
crania (T439.1) from the vomer region and 45 mg was removed from the mandible (T439.2) 76 
in the vicinity of an already damaged area surrounding the right second premolar tooth. 77 
DNA extraction. 78 
Bone fragments were ground to a fine powder using sterilised pestles and mortars. The 79 
powders were weighed and divided into two equal amounts. One set was extracted 80 
immediately for screening using leprosy PCRs, the other was set aside for subsequent 81 
genotyping.  82 
DNA was extracted using an in-house version of the Boom method [5]. In this procedure, 6M 83 
guanidinium thiocyanate (GUSCN, product G9020, US Biologicals, Salem, MA.) containing 84 
1% Triton X-100 (Sigma-Aldrich, T8787) was dissolved in 1x Tris-EDTA buffer (Sigma-85 
Aldrich, T9285) adjusted to pH 6.5 with 3M sodium acetate, pH 5.5 (Ambion,™  product 86 
9740).  Bone powder was mixed with 1ml of the GUSCN buffer on a mixing wheel for 1hr at 87 
4C. The samples were then subjected to 3 freeze-thaw cycles to assist with DNA recovery. 88 
The bone powder was removed by centrifugation at 12,000 x r.p.m. and the supernatant 89 
buffer transferred to a fresh 1.5ml Eppendorf tube. Pre-washed silica suspension (40µl of 90 
0.5-10µm, Sigma-Aldrich, S5631) was added and kept in contact for 3hrs to maximize 91 
recovery of fragmented DNA.  After centrifugation, silica was further washed twice with 1ml 92 
aliquots of GUSCN extraction buffer, followed by 3 washes with 75% ethanol and finally with 93 
1ml of acetone. After thorough drying of the silica pellet, DNA residues were eluted in 60µl 94 
HPLC grade water (Sigma-Aldrich) at 55oC.  These were then sub-divided into 2 x 30 µl 95 
aliquots and stored in low retention plastic tubes to minimize loss of DNA through repeated 96 
freeze- thawing events.  97 
M.leprae screening methods.  98 
Two separate PCR methods were used to screen for the RLEP element, present in 37 99 
copies in the M. leprae genome. In the first of these two methods, product formation was 100 
monitored using the intercalating dye EVAGreen™ (Biotium, Fremont, CA 94538). The 101 
second method employed a FAM labelled hybridization probe. Details of these two methods 102 
have been reported previously [4].  103 
In the present study, a novel PCR method for the REPLEP element (15 copies) was also 104 
used. The sequences of the two primers being: F-5’-TCGGGATAGGTTTTGGGCCAAC-3’ 105 
and R-5’-CTTTAAAGGCCGGCAAGGTGA-3’. These amplified a 119 bp product which was 106 
reported using EvaGreen™. 107 
Finally, we also screened for the 18-kDa antigen locus using primers 18F 5‘- 108 
CTGGACATTGACATCGAACG-3’ and 18R 5’- GCCAAGATCCGTTGGGTGT-3’ which 109 
amplify a 155 bp product.  Experience shows that positivity for this single copy method is a 110 
good indicator that SNP genotyping methods may be successful. 111 
 112 
M.leprae SNP genotyping methods. 113 
A series of PCR methods was used to genotype positive extracts. A number of these, used 114 
for characterising SNP type 3 strains, have been previously published [4,6].  115 
 116 
Screening for Mycobacterium tuberculosis complex DNA. 117 
As tuberculosis (TB) can also cause rhino-maxillary changes [7], and as there is significant 118 
interest in the co-infection of TB and leprosy, extracts were also tested for the presence of 119 
Mycobacterium tuberculosis (MTB) complex organisms using a real- time PCR method for 120 
the IS1081 repetitive element as previously described [8]. 121 
 122 
Human aDNA. 123 
1. Mitochondrial DNA (mtDNA). 124 
Two PCR methods were initially used to look for evidence of human mtDNA. Extracts prepared 125 
from the mandible were tested using primers which amplify a 116 bp region of the human 126 
mitochondrial DNA hypervariable region 1 (HVR-1). The sequences of these primers were:  127 
Forward (L15977-L15998) 5’-CCACCATTAGCACCCAAAGCTA-3’ and  128 
Reverse (H16092-H16070) 5’- ATACATAGCGGTTGTTGATGGGT-3’.  129 
 130 
Another variant of this PCR was used with an alternative reverse primer (H16255-H16236) 131 
with the sequence 5’-CTTTGGAGTTGCAGTTGATG-3’. In combination with the forward 132 
primer, this amplifies a product of 279 bp. 133 
2. Amelogenin. 134 
Although morphology strongly indicated that the skull was from a female, a sex-determining 135 
PCR based on polymorphisms in the amelogenin gene was also applied. In this method, males 136 
are identified by two PCR products, one of 105 bp from the Y chromosome and another of 290 137 
bp from the X chromosome, whereas females generate only the one product of 290 bp. The 138 
sequences of the primers used in this procedure were (F2) 5’-139 
TGACCAGCTTGGTTCTAWCCC-3’ and reverse (R1) 5’-140 
CARATGAGRAAACCAGGGTTCCA-3’ [9]. 141 
A second amelogenin method was also attempted [10]. This generates two bands from males 142 
of 106 bp and 112bp (AMELX and AMELY products respectively), and a single AMELX 143 
product of 106bp from females. 144 
PCR Amplification details. 145 
PCR was performed in a final volume of 15µl, using a hot start Taq kit from Qiagen (product 146 
203445). The reactions contained 25 pmol of forward and reverse primers, each in 1µl, 7.5 147 
µl of the kit master mix, 1.5 µl non-acetylated bovine serum albumin (BSA, 10mg/ml, Sigma 148 
B4287) and 2µl of template. The kit magnesium ion concentration of 1.5 mM per reaction 149 
was supplemented to 2 mM for PCR methods using EVAGreen™ and to 3 mM MgCl2 for 150 
real-time PCR with the RLEP probe. The probe was used at a final concentration of 100 nM. 151 
The volumes were made up to 15 µl with molecular biology grade water (Sigma-Aldrich). 152 
After an initial activation step of 14 min at 95oC, 41 cycles of amplification were performed 153 
on an Mx3005P RT-PCR platform (Agilent Technologies).  154 
The thermal profile of the amplification cycles consisted of denaturation at 95oC for 10s, 155 
annealing (range 52–60oC) for 30s and extension at 72oC for 30s. Fluorescence data was 156 
acquired during the extension step. Melt analyses was performed automatically at the end of 157 
runs monitored with EVAGreen™ and dissociation curves studied to identify likely positives. 158 
Gel electrophoresis and automated DNA sequencing. 159 
PCR products were run out on 3% agarose gels in a TAE buffer system alongside 160 
appropriate DNA size markers (100 bp or 50 bp DNA ladders, Promega) to confirm product 161 
identity. Positive samples for SNP or MLVA typing were bulk purified on 3% (wt/vol) low-162 
melting-point agarose (Invitrogen); bands were excised and purified using a Geneclean DNA 163 
isolation kit (Cat.No.1001-200, mpbio.com). Templates were Sanger sequenced using both 164 
forward and reverse primers by Genewiz UK Ltd., Takeley, Essex, UK. The sequencing 165 
platform used was the Life Technologies 3730xl DNA Analyzer, a 96 capillary instrument. 166 
Measures to prevent contamination. 167 
Separate laboratories were used for each of the three main stages of the aDNA analyses, 168 
these being extraction, amplification and post PCR analysis, such as gel electrophoresis and 169 
purification of products for sequencing. The pre- and post- PCR laboratories were physically 170 
separated and independently equipped with pipettes, fridge-freezers, mixers and bench top 171 
centrifuges, disposable plasticware, filter tips and other reagents dedicated to the project. 172 
Surfaces and equipment in the clean “set-up” laboratory in contact with sample tubes 173 
(centrifuges, rotors, mixers, etc.) were cleaned before each assay. Two control tubes, 174 
comprising reagents less bone powder, were taken through each extraction experiment to 175 
ensure reagents were contamination free. Several template blanks were run alongside bone 176 
extracts in the PCR machine to screen for random contamination. Positive controls were not 177 
included in any of the PCR experiments.  178 
Radiocarbon dating  179 
A sample of bone (0.5g) was taken from the broken end of the woman’s mandible for 180 
radiocarbon dating. Radiocarbon dating was undertaken at the Faculty of Mathematics and 181 
Natural Sciences at the University of Groningen, the Netherlands. The sample underwent 182 
standard chemical cleaning and collagen extraction following an improved version of Longin 183 
[11]. The collagen was combusted into CO2. The CO2 was cryogenically trapped using an 184 
automatic device [12], transformed into graphite, and analysed for 14C by AMS [13]. The 14C 185 
activities were measured relative to a standard radioactivity, corrected for isotopic 186 
fractionation using the stable isotope ratio 13C/12C to d13C = -25 ‰, calculated using the 187 
conventional half-life, and reported in BP [14]. Subsequently, the 14C dates were calibrated 188 
into calendar ages using the internationally recommended calibration curve IntCal13 [15]. As 189 
a by-product of this analysis, stable carbon and nitrogen isotope values were produced, 190 
which are useful for assessing aspects of the woman’s diet.  191 
RESULTS 192 
Biomolecular study. 193 
1. M.leprae screening methods. 194 
Screening methods showed that the female individual was positive for M.leprae DNA, with 195 
the mandible material being more strongly positive than the bone taken from the cranium 196 
(Table 1). In fact, only one of the PCR methods detected M.leprae DNA in the cranial 197 
sample, this being the most sensitive version of the RLEP PCR which employs the 198 
intercalating dye EVAGreen.™ This is shown in Fig. 2. In contrast, all 4 PCRs identified the 199 
pathogen in the extract prepared from the mandible (Table 1). As anticipated, the muliti-copy 200 
targets RLEP and REPLEP exhibited lower Cq values than the single copy 18-kDa locus 201 
(Table 1). Amplification profiles for the RLEP probe method and REPLEP PCR (plus 202 
associated melt curve) are shown in Supplementary material, Figs. S1 and S2 respectively. 203 
Additionally, the REPLEP product was subjected to gel electrophoresis to confirm amplicon 204 
size (Fig. S3). 205 
(See Table 1) 206 
Reproducibility. 207 
Key screening PCR experiments for M.leprae DNA, namely for RLEP using both 208 
EVAGreen™ and specific FAM-labelled probe and for the REPLEP element were repeated 209 
several weeks after the original experiments. The results obtained (not shown) were almost 210 
identical to the original findings seen in Fig. 2 and Figs. S1 and S2 respectively.  All 211 
extraction and non-template controls were negative; showing cross-contamination was not 212 
an issue. 213 
 214 
 215 
Fig.2.216 
2.  SNP genotyping of M. leprae. 217 
SNP genotyping methods were applied to aDNA prepared from the mandible.  The Hoxne 218 
case was found to be SNP type 3, based on the 3 main loci described by Monot and 219 
colleagues [16]. These results are shown in Fig. 3, panels a-c. Further subtyping showed the 220 
strain of leprosy belonged to the 3I lineage [17,18] (Fig.3, panels d-f). The full genotyping 221 
findings are summarised in Table 2. Two SNP loci failed to amplify. These were the 222 
polymorphic loci at nucleotide positions 403,902 and 1,527,056. The latter is useful to further 223 
sub-type 3I strains into either 3I-1 or 3I-2.  We therefore cannot distinguish between these 224 
two alternatives, although the 3I-1 is more likely in archaeological material (see [3, 4]). 225 
 226 
Fig.3.  227 
(See Table 2) 228 
3. VNTR typing. 229 
Neither the AGA(20) nor the GTA(9) loci amplified, so the only variable repeat which was 230 
successful was the 21-3 (ML0058) region, of which 2 copies were present.  Failure of the 231 
triplet repeat loci may indicate a strain with multiple copies of these, with DNA fragmentation 232 
taking template survival below the cut-off point for amplification.  233 
 234 
4. M.tuberculosis complex DNA. 235 
No evidence was found for M.tuberculosis complex DNA in the Hoxne case. 236 
 237 
Human DNA. 238 
1. mtDNA.  239 
A PCR product was obtained with the primer pair (L15977-L15998) and (H16092-H16070) 240 
which generate a 116 bp product (Fig. S4 in Supplementary material). However, attempts to 241 
generate the longer amplicon of 279 bp with primer pair (L15977-L15998) and (H16255-242 
H16236) were unsuccessful. 243 
2. Amelogenin. 244 
No PCR products were obtained with either version of the amelogenin methods we used, 245 
which probably reflects the extremely fragmented nature of DNA in this skeleton.   246 
Radiocarbon dating and stable isotopes.  247 
Analysis of the sample (GrA-66655) demonstrated that the quality of the bone collagen was 248 
good with C/N ratio of 3.3. In addition, it appeared from the carbon and nitrogen stable 249 
isotope results that there was no reservoir effect affecting the results with δ13C (‰) of 19.78 250 
and δ15N (‰) of 11.03. The uncalibrated date was 1105+/-30BP. The calibrated dating 251 
revealed that the woman likely lived sometime between 885-1015 AD (2-sigma), confirming 252 
the pre-Norman date. 253 
As part of the radiocarbon dating of the jaw bone, stable isotope values for carbon and 254 
nitrogen were produced, as mentioned above. Although there has been limited isotopic 255 
research in this region for the 10th and 11th centuries, some information is available. In a 256 
study of East Anglian Anglo-Saxon diet, presented values for three sites of a similar date to 257 
the woman from Hoxne: Caistor-by Yarmouth, Burgh Castle and South Acre [19]. The values 258 
for the woman from Hoxne fit well with these sites.  259 
The values for carbon suggests that the woman was likely to have been eating a diet based 260 
largely on c3 terrestrial plants, which considering the time period, is likely to consist of 261 
wheat, barley, pottage. The nitrogen isotope values suggest that she is likely to have 262 
consumed some animal protein.  263 
 264 
DISCUSSION. 265 
The aim of this research was to confirm the macroscopic diagnosis of leprosy in the woman 266 
found in Hoxne through the detection of the mycobacteria responsible for the disease. In 267 
addition, it was desirable to know which strain of the disease the woman was suffering from 268 
and when she had lived. The results indicate that she was infected with leprosy, of which the 269 
strain belongs to the 3I branch of the M.leprae phylogenetic tree.  Modern 3I-1 isolates 270 
display T and G bases at nucleotide positions 7,614 and 1,113,926 respectively. In the 271 
Hoxne skull, the SNPs were T and A respectively. This appears to be an intermediate 272 
genotype between what would be expected from other genotypes (including type 3 strains 273 
other than 3I) namely C and A and implies that this woman was infected with a strain which 274 
may have been ancestral to modern 3I exemplars. We have previously found the same 275 
combination at these loci in a case of leprosy from Great Chesterford [3].  The Great 276 
Chesterford case was earlier, with a calibrated radiocarbon date of 415-545 AD, whereas the 277 
present skull was dated between 885-1015 AD. Therefore, very similar strains of leprosy 278 
persisted for several hundred years in this part of Britain.  279 
The strain type has little bearing on the pathogenesis or severity of disease, as this is dictated 280 
by the individual’s immune response to M. leprae, but rather assists in understanding the origin 281 
of disease in the Anglo-Saxon period. Other type 3I cases have been reported from medieval 282 
Britain (Winchester and Ipswich), Denmark and Sweden [4, 20].  Bearing in mind the location 283 
of the latter two, a Scandinavian origin for this lineage remains one possibility, given the 284 
proximity of the Anglo-Saxon tribal homelands in Northern Germany with Denmark, and the 285 
significant population movements that took place between Britain and this region in the Anglo-286 
Saxon period.  287 
Although the total evidence from the early medieval period is limited to around a score of 288 
cases, at present it does seem that the 3I genotype was one of two predominant lineages 289 
associated with the rise in disease in Britain in the early and high medieval periods.  There is 290 
also evidence to suggest that the 3I lineage was present in Britain much later in the timeline 291 
of European leprosy, which had begun to decline by the 13th century [21]. An earlier study 292 
found this lineage in a case from 13th-16th Suffolk [6, 22]. This lineage is now found in southern 293 
states of the United States of America and it was likely taken to the New World by early 294 
European settlers. Given persistence of the 3I lineage over nearly 800 years, it seems unlikely 295 
that a change in genetic makeup of the bacillus was responsible for the decline in European 296 
leprosy: an inference confirmed by comparison of present day 3I whole genomes with those 297 
recovered from both Winchester and Scandinavia [23] which revealed remarkably high 298 
degrees of conservation amongst the ancient and modern strains.  299 
Although indigenous human leprosy has been absent from the British Isles for over 200 years, 300 
a recent study demonstrated M.leprae infection in red squirrels on Brownsea Island, Dorset, 301 
UK. Interestingly, sequencing of the red squirrel M. leprae strain showed it to be most closely 302 
related to an ancient M. leprae that was detected in medieval human skeletal remains (SK2, 303 
Sk7 and Sk19) from Winchester, UK [23, 24]. These strains were Type 3I, similar to that 304 
detected here in the woman from Hoxne. An attractive theory is that leprosy is, in part, partially 305 
a zoonotic infection that can be passed from human to human, between armadillos and 306 
humans [18] and also from squirrel to human. Historically, this route of transmission is made 307 
viable by the common usage of squirrel for fur and meat in the medieval period and it is known 308 
that squirrel fur was imported into the East Anglia from Scandinavia and the Baltic region [25]. 309 
However, it is questionable how long the bacteria could survive in meat or fur to be transmitted, 310 
but it is notable that squirrels were occasionally kept as pets. Thus, while contact with squirrels 311 
has declined and human disease has been eliminated in the UK, a reservoir of M. leprae 312 
remains in the red squirrel.  It is also of note that the British red squirrel population also 313 
harbours another leprosy causing bacterium, M. lepromatosis, which has been shown to cause 314 
human disease predominantly in Mexico [26]. No modern or ancient human leprosy in Europe 315 
has yet been demonstrated to be caused by M. lepromatosis but it remains possible that this 316 
bacterium may also be an aetiologic agent of leprosy in the British Isles. 317 
There is a long existence of leprosy in the east of Britain, which is evidenced by the foundation 318 
of many leper hospitals or leprosaria in East Anglia from the 11th century onwards. Examples 319 
close to Hoxne include the suburban examples at Eye, 4 miles to the southeast, Eccles 20 320 
miles to the north east (both dedicated to St. Mary Magdalene) and Little Snoring some 45 321 
miles to the north. Norwich itself was known to have at least four houses dedicated to the care 322 
of those with leprosy, including the still-standing example at St. Margaret in Sprowston to the 323 
north east of the medieval town. There were several hospitals just outside the city gates, such 324 
as St. Giles and St. Benedict’s to the west and St. Leonard’s and St. Mary Magdalen and St. 325 
Clements’ to the north.  Other East Anglian towns with leprosaria included Dunwich, Ipswich, 326 
King’s Lynn, Sudbury and Great Yarmouth. Indeed, some of the later foundations, that is after 327 
1350 AD, were in this part of Britain including Walsingham, founded pre 1486 [21].  328 
Significantly, the confirmation of leprosy causing mycobacteria in the woman from Hoxne adds 329 
to a growing number of pre-Norman and early Norman cases (see Table 3 and Fig. 4) in 330 
Britain. When putting the case in context with others prior to the widespread foundation of 331 
hospitals, a number of trends can be noted. First, it appears that the earliest cases come from 332 
the south west of the country, although it would be useful to subject these to radiocarbon 333 
dating and aDNA analyses. In the early Anglo-Saxon period, with the exceptions of Beckford 334 
and Cannington in the south west, the other cases are in the east, especially East Anglia, with 335 
five cases being found along the route of the Icknield Way, an important travel route partly 336 
linking the south west, where the earliest cases are, and the east (see Fig. 4). In the Middle 337 
Saxon period cases can be found at eight sites, including the Hoxne case. Half are still found 338 
in East Anglia with one in nearby Northamptonshire. Cases are also found at two sites in 339 
Yorkshire and in the Scilly Isles. This appearance of later cases in a more northerly location 340 
has already been highlighted by others [27].  341 
 342 
(See Table 3) 343 
 344 
Fig.4. 345 
The appearance of so many leprosy cases in the (East) Anglia region is noteworthy as it could 346 
potentially suggest that the disease was endemic in this region earlier than other parts of the 347 
country. There are many problems with determining the prevalence of a disease from 348 
archaeological material, as is cautioned by Roberts [27], so there could be a number of 349 
explanations for this trend, some of which could be interconnected. While it is not the purpose 350 
of this paper to fully explore them here, and much radiocarbon dating and aDNA research is 351 
required, some themes can be highlighted. First, it is important to consider that there is a 352 
general excavation bias in the region of analysis. In relation, it is possible that this trend is a 353 
result of archaeological excavation bias due to the development of places with early medieval 354 
precursors. However, one may expect cases from locations near cities that have had 355 
significant development and/or have rapidly expanded beyond their early medieval borders 356 
into the hinterland, such as London, Nottingham and Bristol.  357 
A further factor may relate to preservation. In particular, the sites yielding cases in the East 358 
Anglia region are places dominated by chalk. This leads to very good skeletal preservation, 359 
and it could be argued that the number of cases could be related to their survival to discovery. 360 
However, there are other parts of Britain that have similar geology, for example Hampshire 361 
and Dorset, and while many early Anglo-Saxon cemeteries have been excavated (e.g. Alton, 362 
Worthy Park and Appledown) no leprosy cases have been recovered at present.  363 
It is also pertinent to consider population densities at the time when leprosy was becoming 364 
endemic in Britain. East Anglia had many of the most densely populated areas, including 365 
Norwich, Ipswich, Thetford and Lincoln. Although leprosy is mostly a disease of the 366 
countryside today [28], it can also have a high urban presence [29]. It is therefore possible 367 
that increasing population density, and/or interconnectedness between rising towns and the 368 
rural hinterland, may have provided opportunities for the disease to survive and spread in this 369 
region. However, if purely related to density, one would expect more cases from other regions 370 
with high density, although the later cases from York, a region also with high population density 371 
in the medieval period, could support this idea.  372 
If the trends in the current evidence remain true, and as it appears that the strain identified 373 
here came from the Scandinavia region via the Anglo-Saxon homelands and/or later Viking 374 
activities, some explanation may lay in the significant movement in and between East Anglia 375 
and the continent. In addition, strong trade connections existed between the two regions. Even 376 
more intriguing is the fact that King’s Lynn and Yarmouth became very significant for fur 377 
import, including Scandinavian and Baltic squirrel, in the Medieval period [25]. Perhaps then 378 
it is the prolonged connection between these two regions that is important in the disease’s 379 
history in the UK. In addition, as potentially three of the earliest case are actually in the west 380 
of England, it would be very interesting to see if they have the same strain, which may point 381 
to a first appearance of the disease in the west. Further research confirming or refuting these 382 
trends, as well as the role of the fur trade could be highly enlightening and exciting.  383 
CONCLUSION.  384 
The aim of this research was to confirm the macroscopic diagnosis of leprosy in a female 385 
individual excavated from a garden in Hoxne, Norfolk. In addition, it was desirable to know 386 
which strain of the disease she had, and how this fits into our current knowledge of the disease 387 
in Britain and beyond. Genetic analysis detected M. leprae in the cranium and mandible. SNP 388 
typing demonstrated that the strain was from the third branch of the phylogenetic tree, subtype 389 
I. This (sub)type has also been identified at Great Chesterford in a 5th to 6th century man. 390 
Radiocarbon dating demonstrated that the woman from Hoxne lived later, sometime between 391 
885-1015AD, demonstrating the persistence of this strain in the region. In addition, her 392 
discovery adds to the growing number of pre-Norman and Norman leprosy cases in Britain of 393 
which over half are in East Anglia or surrounding regions. It is possible that this apparent 394 
clustering could relate to Anglo-Saxon and Viking movements, trade and/or the high 395 
population density that existed in this region during the Anglo-Saxon period, although 396 
excavation and preservation factors could be compounding the picture. Further research 397 
should focus on exploring these possibilities and their interconnectedness to improve our 398 
understanding of the origins and spread of the disease in Britain and its connected regions.  399 
AUTHOR STATEMENTS.  400 
Funding: This work received no specific grant from any funding agency.  401 
Acknowledgements: Many thanks are due to Tim Holt-Wilson for drawing our attention to the 402 
skull from Hoxne. To Daisy Fearns and Shirley Farrow from Diss Museum for their help in 403 
sampling the material. Thanks are also given to Corinne Duhig, John Robb, Susanne 404 
Hakenbeck, Simon Mays and Jenna Dittmar for their thoughts on this manuscript. Our 405 
gratitude is sent to The Friends of Diss Museum for their generous donation for radiocarbon 406 
dating.  407 
Conflicts of interests: The authors have declared that no competing interests exist.  408 
Ethical Statement: The date of the human skeletal remains means that it is not subject to the 409 
Human Tissue Act 2004. The skull was disturbed accidently on private land. As such no 410 
permissions for excavation was required.  411 
 412 
REFERENCES. 413 
1. Anderson S. The Human Skeletal Remains from Timberhill, Castle Mall Norwich 414 
(Excavated 1989-1991). AML Report 1996; No. 73/96. 415 
2. Møller-Christensen V. Bone Changes in Leprosy. Copenhagen: Munksgaard; 1961. 416 
3. Inskip SA, Taylor GM, Zakrzewski SR, Mays SA, Pike AWG et al. Osteological, 417 
biomolecular and geochemical examination of an Early Anglo-Saxon case of lepromatous 418 
leprosy. PLoS ONE 2015; 10(5):e0124282.  419 
4. Taylor GM, Tucker K, Butler R, Pike AWG, Lewis J et al.  Detection and strain typing of 420 
ancient mycobacterium leprae from a medieval leprosy hospital. PLoS ONE 2013; 421 
8(4):e62406.  422 
5. Boom R, Sol CJ, Salimans MM, Jansen CL, Wertheim-van Dillen PM et al. Rapid and 423 
simple method for purification of nucleic acids, J Clin Microbiol 1990; 28:495–503. 424 
6. Taylor GM, Blau S, Mays SA, Monot M, Lee OY-C et al. Mycobacterium leprae 425 
Genotype Amplified from an Archaeological Case of Lepromatous Leprosy in Central Asia. J 426 
Archaeol Sci 2009; 36:2408-2414.  427 
7. Ortner DJ. Identification of Pathological Conditions in Human Skeletal Remains. London: 428 
Academic Press; 2003. 429 
8. Mays S, Ogden A, Montgomery J, Vincent S, Battersby W, Taylor GM. New light on 430 
the personal identification of a skeleton of a member of the crew of Sir John Franklin’s last 431 
expedition to the Arctic, 1845.  J Archaeol Sci 2011; 38:1571– 1582. 432 
9. Waldron HA, Taylor GM, Rudling DR. Sexing of Romano-British Baby Burials from the 433 
Beddingham and Bignor Villas. Sussex Archaeological Collections 1999; 137:71-79. 434 
10. Mannucci A, Sullivan KM, Ivanov PL, Gill P. Forensic application of a rapid and 435 
quantitative amplification of the homologous gene amelogenin. Int J Legal Med 1994; 436 
106:190-193. 437 
11. Longin R. New method of collagen extraction for radiocarbon dating. Nature 1971; 438 
230:241–242.  439 
12. Aerts AT, van der Plicht J, Meijer HAJ. Automatic AMS sample combustion and CO2 440 
collection. Radiocarbon 2001; 43:293-298. 441 
13. Plicht JVD, Wijma S, Aerts AT, Pertuisot MH, Meijer HAJ.  Status report: The 442 
Groningen AMS facility. Nuclear Instruments & Methods in Physics Research Section B-443 
Beam Interactions with Materials and Atoms 2000; 172(1):58-65.  444 
14. Mook WG, van der Plicht J. Reporting 14C activities and concentrations. Radiocarbon 445 
1999; 41(3):227–239. 446 
15. Reimer PJ, Bard E, Bayliss A, Beck JW, Blackwell PG et al.  IntCal13 and Marine13 447 
Radiocarbon age calibration curves 0-50,000 years cal BP. Radiocarbon 2013; 55:1869-448 
1887. 449 
16. Monot M, Honoré N, Garnier T, Araoz R, Coppée JY et al. On the origin of leprosy. 450 
Science 2005; 308:1040–1042. 451 
17. Monot M, Honoré N, Garnier T, Zidane N, Sherafi D et al.  Comparative genomic and 452 
phylogeographic analysis of Mycobacterium leprae. Nature Genetics 2009; 41:1282–1289.  453 
18. Truman RW, Singh P, Sharma R, Busso P, Rougemont J et al. Probable zoonotic 454 
leprosy in the Southern United States. N Engl J Med 2011; 364:1626–1633.  455 
19. Hull BC, O Connell T. Diet: Recent evidence from analytical chemical techniques, In: 456 
Hamerow H, Hinton D, Crawford S (editors). The Oxford Handbook of Anglo-Saxon 457 
Archaeology. Oxford: Oxford University Press; 2011. pp. 667-687. 458 
20. Economou C, Kjellström A, Lidén K, Panagopoulos I. Ancient-DNA reveals an Asian 459 
type of Mycobacterium leprae in medieval Scandinavia. J Archaeol Sci 2013; 40:465–470.  460 
21. Rawcliffe C. Leprosy in Medieval England. Suffolk, UK; Boydell Press; 2006. 461 
22. Taylor GM, Watson CL, Lockwood DNJ, Mays SA. Variable Nucleotide Tandem 462 
Repeat (vntr) Typing of Two Cases of Lepromatous Leprosy from the Archaeological 463 
Record.  J Archaeol Sci 2006; 33: 1569-1579. 464 
23. Schuenemann VJ, Singh P, Mendum TA, Krause-Kyora B, Jäger G et al. Genome-465 
wide comparison of medieval and modern Mycobacterium leprae. Science 2013; 12: 466 
341(6142), 179–183.  467 
24. Mendum TA, Schuenemann VJ, Roffey S, Taylor GM, Wu H et al. Mycobacterium 468 
leprae genomes from a British medieval leprosy hospital: towards understanding an ancient 469 
epidemic. BMC Genomics 2014; 15:270.  470 
25. Veale EM.  The English Fur Trade in the Later Middle Ages. Oxford: Clarendon Press; 471 
1966. 472 
26. Han XY, Seo YH, Sizer KC, Schoberle T, May GS et al. A new Mycobacterium species 473 
causing diffuse lepromatous leprosy.  Am J Clin Pathol 2008; 130: 856-864. 474 
27. Roberts C. The antiquity of leprosy in Britain: The skeletal evidence. In: Roberts C, 475 
Lewis ME, Manchester K (editors). The Past and Present of Leprosy: Archaeological, 476 
Historical, Palaeopathological and Clinical Approaches. British Archaeological Reports 477 
(BAR) International Series (1054). Oxford; Archaeopress; 2002. pp. 213-222. 478 
28. Aufderheide AC, Rodriguez C. The Cambridge Encyclopedia of Human 479 
Palaeopathology. Cambridge: Cambridge University Press; 1998. 480 
29. Roberts C, Cox M. Health and Disease in Britain. Prehistory to the Present Day. 481 
Gloucestershire, UK:  Sutton Publishing; 2003.  482 
30. Reader R. New evidence for the antiquity of leprosy in early Britain.  J Archaeol Sci 483 
1974; 1: 205–207.  484 
31. Brothwell DR, Powers R. The Human Bones. In: Rahtz P, Hirst SM, Wright SW 485 
(editors). Cannington Cemetery. Britannia Monograph Series 17. London: Society for 486 
Promotion of Roman Studies; 2000. pp. 132–256. 487 
32. Wells C. A possible case of leprosy from a Saxon cemetery at Beckford. Med Hist 1962; 488 
6: 382–386. 489 
33. Evison VI, Hill P. Two Anglo-Saxon cemeteries at Beckford, Hereford and Worcester. 490 
York: Council for British Archaeology; 1996.  491 
34. Anderson S. The Human Bone. In: Caruth J, Hines J (editors). The Anglo-Saxon 492 
Cemeteries at RAF Lakenheath, Eriswell, Suffolk. Excavations 1997–2008. East Anglian 493 
Archaeology. Oxford: Oxbow Books. in press.  494 
 495 
35. Roberts C. A note on skeletons C and E from Burial 62/63/64. In: Kinsley AG (editor). 496 
Broughton Lodge. Excavations on the Romano-British Settlement and Anglo-Saxon 497 
cemetery at Broughton Lodge, Willoughby-on-the-Wolds, Nottinghamshire 1964–8. 498 
Nottingham Archaeological Monographs No. 4. Nottingham: University of Nottingham; 1993. 499 
pp. 58.  500 
 501 
36. Duhig C. The Human Skeletal Material. In: Malim T, Hines H (editors). The Anglo-Saxon 502 
Cemetery at Edix Hill (Barrington A), Cambridgeshire. York: Council for British Archaeology; 503 
1998. pp. 154-199. 504 
37. Møller-Christensen V, Hughes DR. Two early cases of leprosy in Great Britain. Man 505 
1962; 62; 177– 179. 506 
38. Beavan N, Mays S. The Human Skeletons. In: Hines J, Bayliss A, Høilund Nielsen K, 507 
McCormac FG, Scull C (editors). Anglo-Saxon Graves and Grave Goods of the 6th and 7th 508 
Centuries AD: A Chronological Framework. Society for Medieval Archaeology Monograph 509 
33. London: Society for Medieval Archaeology; 2013. pp. 101–131. 510 
39. Manchester K. A leprous skeleton from the 7th century from Eccles, Kent, and the 511 
present evidence of leprosy in early Britain.  J Archaeol Sci 1981; 8: 205–209. 512 
40. Brothwell DR. The Palaeopathology of early British man: An essay on the problems of 513 
diagnosis and analysis. J R Anthropol Inst 1961; 91: 318–344. 514 
41. Anderson S. Cemeteries and People. In: Tester A, Anderson S, Riddler I, Carr R 515 
(editors). Staunch Meadow, Brandon, Suffolk: A High Status Middle Saxon Settlement on the 516 
Fen Edge. East Anglian Archaeology 151. Oxford: Oxbow Books; 2014. pp. 186–218. 517 
42. Powell F. The human remains, In: Boddington A (editor). Raunds Furnells: The Anglo-518 
Saxon Church and Churchyard. English Heritage Archaeological Monographs 7. Swindon: 519 
English Heritage: 1996. pp. 113-124.  520 
43. Mays S. The Medieval Burials from the Blackfriars Friary, School Street, Ipswich, Suffolk 521 
(Excavated 1983-5). Ancient Monuments Laboratory Report 1989;16/91 (part 1).  522 
44. Brothwell DR. Evidence of leprosy in British archaeological material. Med Hist 1958; 2: 523 
287-291. 524 
45. Phillips D, Heywood B. Excavations at York Minster. From Roman Fortress to Norman 525 
Cathedral. Part 2: The Finds. London: Royal Commission on Historical Monuments 526 
(England); 1995. 527 
46. Mays S. The human remains. In: Mays S, Harding C, Heighway C. Wharram. A Study of 528 
Settlement on the Yorkshire Wolds IX. York: York University Archaeological Publications; 529 
2007. pp. 77-192.  530 
 531 
TABLES. 532 
Table 1. 533 
M.leprae  PCR locus 
(reporter). 
Amplicon  
Size (bp) 
Skull T439.1 
Result  
(Cq) 
Mandible T439.2 
Result 
(Cq) 
RLEP  (EvaGreen™) 111 + 
(37.22) 
++ 
(29.75) 
RLEP  (FAM probe) 78 - 
(no ct) 
++ 
(30) 
REPLEP (EvaGreen™) 119  
ND 
++ 
(30.1) 
18-kDa (EvaGreen™) 155 - 
(No ct) 
+ 
(34.49) 
 534 
Table 2. 535 
Locus Amplicon 
Size (bp) 
Nucleotide 
Base. 
SNP typing inference. 
SNP 1 
14,676 
136 C  
 
type 3 SNP 2 
1,642,879 
122 T 
SNP 3 
2,935,693 
107 C 
SNP 4 
413,902 
120 Fail  
SNP 5 
591,857 
107 C subtypes I-L 
SNP 6 
1,133,495 
121 T subtype I 
SNP 7 
2,312,066 
120 C subtypes I or J 
SNP 8 
7,614 
109 T  
 
subtype I SNP 9 
1,113,926 
117 A 
SNP10 
1,104,235 
117 G type 3 
SNP 12  
1,527,056 
101 Fail  
Indel 17915  
11 bp repeat 
120 1 copy* subtype I 
Overall   3I 
 536 
 537 
 538 
 539 
 540 
Table 3. 541 
Site Century 
AD 
Number of 
cases 
Source 
Poundbury, Dorset 4th  1 30 
Cirencester, Gloucestershire Roman 1 28  
Great Chesterford, Essex 5th  1 3 
Cannington, Somerset 5th  1 31 
Beckford, Gloucestershire 6th  1 32,33 
Eriswell, Suffolk 5th-7th  4 34 
Broughton lodge, 
Nottinghamshire 
5-7th 1 35 
Barrington A (Edix Hill), 
Cambridgeshire 
6th-7th 1 36 
Burwell, Cambridgeshire 7th  1 37 
Marina Drive, Dunstable  7th  1 38 
Eccles, Kent 7th  1 39 
Tean, Scilly Isles 7th-8th  2 40 
Staunch Meadow, Brandon, 
Suffolk 
Middle 
Saxon 
1 41 
Hoxne, Norfolk 9th-10th  1 This study 
Raunds, Northamptonshire 10th-12th c 3   42 
School Street, Ipswich 10th-11th 2 43 
St. Catherine's, Thorpe, 
Norwich 
Late Saxon 1 44 
York Minster 8th 
onwards 
2 45 
Wharram Percy, Yorkshire 10-12th 1 46 
 542 
543 
LEGENDS TO TABLES. 544 
 545 
Table 1. Results of PCR screening methods for M.leprae DNA.  546 
- = PCR negative; + = Weak positive; + = Positive; ++ = Strong positive 547 
All extracts were tested in duplicate and the mean Cq (cycle of quantitation) values are 548 
shown in parentheses. 549 
 550 
Table 2.  SNP genotyping of Hoxne case. 551 
 552 
Table 3. Cases of pre-Norman and early Norman cases of leprosy in the east region of 553 
Britain. 554 
555 
LEGENDS TO FIGURES. 556 
 557 
Fig.1. Left, remodelling of the nasal aperture and spine in cranium T439.1. Right, frontal 558 
view of the skull.  559 
 560 
Fig.2. Upper panel: RLEP PCR method showing amplification profile for the Hoxne skull 561 
(blue traces) and mandible (green traces). Lower panel shows the dissociation or melt 562 
curves for these samples. Note primer-dimer generation is seen in the water blanks (black 563 
traces) but this product melts at a far lower temperature (77C) compared to the specific 564 
RLEP amplicon (91C). Sequencing confirmed identity of the RLEP amplicon. 565 
 566 
Fig. 3.  Sequencing of phylogenetically informative loci from the strain of M.leprae amplified 567 
from the Hoxne mandible. Panels a-c show C at nucleotide position 14,676, T at 1,642,879 568 
and C at 2,935,693 respectively, indicating a main SNP type 3. Panels d-f show T at position 569 
1,133,495, T at 7,614 and A at 1,113,926, further indicating a sub-type I. In each case, SNPs 570 
of interest are highlighted with a yellow bar in each panel. Nucleotide positions refer to the 571 
Tamil Nadu (TN) reference strain of M.leprae. 572 
 573 
Fig. 4. Map demonstrating the distribution of pre-Norman and early Norman cases of Leprosy 574 
in Britain. Note: Tean cases not shown.  575 
 576 
 577 
